APOTEA — Apotea Sverige AB Share Price
0.000.00%
Last trade - 00:00Consumer DefensivesSpeculativeMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 33.63 | ||
| PEG Ratio (f) | 12.06 | ||
| EPS Growth (f) | 2.87% | ||
| Dividend Yield (f) | 0.7% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 35.59% | ||
| Return on Equity | 42.18% | ||
| Operating Margin | 4.06% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | 4,579.5 | 4,882.8 | 5,450.2 | 6,541.1 | 7,488.5 | 8,572.5 | 12.62% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -82.9 | +337.19 | -94.65 | -8.66 | +29.98 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Apotea Sverige AB, formerly Apotea AB, is a Sweden-based online pharmacy. The Company offers both non-prescription products and prescription products for home pharmacy, regardless of whether it is a cold, pollen allergy , sun protection, upset stomach , fever & aches , diarrhea , head lice, constipation or treatment for migraines. Its pharmacists provide advice on everything from eczema, hemorrhoids, back pain, period pain, chicken pox, sinusitis to winter sickness, constipation and sensitive stomach. The Company owns premises with a prescription business on Lidingo in Stockholm, as well as an office and recipe business at Norrtull in Stockholm. The Company also offers online chats and conversations with pharmacists, self-care advisors, skin therapists and veterinarians in addition to pharmacists
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- January 1st, 1970
- Incorporated
- November 13th, 2003
- Public Since
- January 1st, 1970
- No. of Employees
- 831
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- OMX Nordic Exchange Stockholm
- Address
- Sveavagen 168, STOCKHOLM, 113 46
- Web
- https://www.apotea.se/
- Phone
- +46 87509220
- Auditors
Upcoming Events for APOTEA
Similar to APOTEA
Axfood AB
OMX Nordic Exchange Stockholm
EQL Pharma AB
OMX Nordic Exchange Stockholm
Herno Gin AB
OMX Nordic Exchange Stockholm
Newbury Pharmaceuticals AB
OMX Nordic Exchange Stockholm
Viva Wine AB
OMX Nordic Exchange Stockholm
FAQ
What is the Apotea Sverige AB share price?
As of Today at 19:17 UTC, shares in Apotea Sverige AB are trading at SEK76.80. This share price information is delayed by 15 minutes.
How has the Apotea Sverige AB share price performed this year?
Shares in Apotea Sverige AB last closed at SEK76.80 and the price had moved by over the past 365 days. In terms of relative price strength the Apotea Sverige AB share price has matched the FTSE Global All Cap Index by over the past year.
What are the analyst and broker recommendations for Apotea Sverige AB?
The overall consensus recommendation for Apotea Sverige AB is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Apotea Sverige AB dividend yield?
Apotea Sverige AB does not currently pay a dividend.
Does Apotea Sverige AB pay a dividend?
Apotea Sverige AB does not currently pay a dividend.
When does Apotea Sverige AB next pay dividends?
Apotea Sverige AB does not currently pay a dividend.
How do I buy Apotea Sverige AB shares?
To buy shares in Apotea Sverige AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Apotea Sverige AB?
As of the previous close price of SEK76.80, shares in Apotea Sverige AB had a market capitalisation of .
Where are Apotea Sverige AB shares listed?
Here are the trading details for Apotea Sverige AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: APOTEA
What kind of share is Apotea Sverige AB?
Based on an overall assessment of its quality, value and momentum Apotea Sverige AB is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Apotea Sverige AB share price forecast for 2025?
The analyst consensus target price for shares in Apotea Sverige AB is SEK74.00. That is 3.65% below the last closing price of SEK76.80.
Analysts covering Apotea Sverige AB currently have a consensus Earnings Per Share (EPS) forecast of SEK2.09 for the next financial year.
Find out moreWhat is the trend in the Apotea Sverige AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Apotea Sverige AB. Over the past six months, its share price has matched the FTSE Global All Cap Index by .
As of the last closing price of SEK76.80, shares in Apotea Sverige AB were trading -0.72% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Apotea Sverige AB PE Ratio?
The Apotea Sverige AB PE ratio based on its reported earnings over the past 12 months is 33.63. The shares last closed at SEK76.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Apotea Sverige AB?
We do not have data on Apotea Sverige AB's directors